BiotechTube
Home/IsomAb/Dr Philip Brainin
DP

Dr Philip Brainin

Chief Executive Officer

IsomAb

Therapeutic Areas

Cardiovascular

IsomAb Pipeline

DrugIndicationPhase
ISM-001Chronic Stable Angina (Coronary Artery Disease)Pre-clinical

Leadership Team at IsomAb

JA
Julian Attfield
Chief Financial Officer/Company Secretary
PD
Professor David Bates
Chief Scientific Officer
DG
Dr Gary Burgess
Chief Medical Officer
View full IsomAb profile